Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01730261 · ClinicalTrials.gov registry record · Phase 1
Online Emotional Regulation Group Treatment
A Phase 1 study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- Phase 1
- Development phase
- 147
- Enrollment target
NCT01730261 is a Phase 1 study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 147 participants.
The verdict
NCT01730261, a Phase 1 study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 147 participants
- Enrollment target
Study Summary
This study will examine the feasibility of online delivery of emotional regulation training to individuals with TBI with emotional dysregulation. 80 subjects with significant emotional dysregulation will be enrolled and will receive 24 60-minute emotional regulation sessions twice a week for 12 weeks, delivered online in group modality. Attendance and compliance will be tracked, and outcomes will be monitored using online data collection methods. Treatment satisfaction and participant subjective experience will also be assessed.
Interventions
- BEHAVIORAL Online Emotional Regulation Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 147 participants |
| Start Date | 2012-11 |
| Est. Completion | 2015-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01730261
The ClinicalTrials.gov registry entry for NCT01730261 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 147 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Online Emotional Regulation Treatment is the first listed.
NCT01730261 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01730261 about?
NCT01730261 is a clinical study titled "Online Emotional Regulation Group Treatment". This study will examine the feasibility of online delivery of emotional regulation training to individuals with TBI with emotional dysregulation. 80 subjects with significant emotional dysregulation will be enrolled and will receive 24 60-minute emotional regulation sessions twice a week for 12 week...
What is the current status of trial NCT01730261?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 147 participants. The study started on 2012-11. Estimated completion is 2015-10.
What interventions are being tested in trial NCT01730261?
The interventions under investigation include: Online Emotional Regulation Treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT01730261?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.